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Introduction. The treatment requirements for high-grade Ta, T1 and T2 bladder cancers differ 
considerably, thus a correct disease staging is extremely important. The disease staging is often 
underestimated during primary resection. Upon the histological assessment of T1 bladder 
cancer, the probability of detecting a muscle-invasive bladder cancer after a secondary 
resection ranges between 1.3% to 25% and it might increase up to 45% in absence of detrusor 
muscle fragments at first morphopathological examination. Secondary bladder resection might 
enhance a relapse-free patient survival, improve BCG treatment outcomes and yield significant 
prognostic data. 
Aim of the study. To evaluate secondary transurethral resections of the bladder tumors in order 
to assess the treatment outcomes. 
Materials and methods.. Over the January 2018 - August 2019 period, 54 patients underwent 
a secondary transurethral resection at the Urology Clinic of "N. Testemitanu" SUMPh.  The 
data analysis of the performed interventions, histopathological examination, disease staging 
and dynamic assessment of the patients was carried out. 
Results. The histopathological examination identified detrusor muscle after a primary 
resection in 72% cases. The secondary resection revealed residual tumors in 28% patients with 
Ta stage and in 35% patients with T1 stage. 68% of residual tumors were detected within the 
initial resection area. The progression and staging of the pathology were found in 7% (from Ta 
to T1) and in 11% (from T1 to T2) cases. 
Conclusions. Residual tumors commonly occur following a transurethral resection of high-
risk non-muscle invasive bladder cancers. The secondary resection procedure helps in 
diagnosing residual tumors and may improve the treatment outcomes, which have been initially 
assessed as T1 stage. 
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Introduction. Nowadays, patients suffering from the sclerosis of prostate became a global 
health problem. The main trigger factor is the presence of chronic prostatitis. This is a 
